|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
03-27-2010, 03:09 AM
|
|||
|
|||
Astellas Pharma's proposed acquisition of OSI Pharmaceuticals: HSR waiting period exp
Astellas Pharma Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to Astellas' proposed acquisition of OSI Pharmaceuticals Inc. has expired.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bayshore Home Health announces acquisition of CCT | cancerfr | Mesothelioma | 0 | 08-04-2010 05:23 PM |
| MDRNA, Inc. Shareholders Approve Acquisition of Cequent Pharmaceuticals | cancerfr | Adrenocortical Carcinoma | 0 | 07-23-2010 01:50 PM |
| Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Off | cancerfr | Adrenocortical Carcinoma | 0 | 07-12-2010 03:30 PM |
| Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Off | cancerfr | Adrenocortical Carcinoma | 0 | 07-12-2010 01:03 PM |
| Astellas Pharma's proposed acquisition of OSI Pharmaceuticals: HSR waiting period exp | cancerfr | AIDS-related cancer | 0 | 04-01-2010 04:05 AM |
Linear Mode
